Early minimally invasive surgery for brain bleeds shows mixed results
Trial shows no long-term benefit of minimally invasive clot removal for brain bleeds, despite early safety and recovery signals
In the MIND randomized clinical trial of 236 adults with spontaneous supratentorial intracerebral hemorrhage, minimally invasive surgery with the Artemis Neuro Evacuation Device did not improve 180 day disability or reduce 30 day mortality versus guideline based medical management.
